- Home
- TARS vs PZZA Comparison
TARS vs PZZA Comparison
Compare TARS & PZZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- PZZA
- Stock Information
- Founded
- TARS 2016
- PZZA 1984
- Country
- TARS United States
- PZZA United States
- Employees
- TARS N/A
- PZZA N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- PZZA Restaurants
- Sector
- TARS Health Care
- PZZA Consumer Discretionary
- Exchange
- TARS Nasdaq
- PZZA Nasdaq
- Market Cap
- TARS 1.7B
- PZZA 1.5B
- IPO Year
- TARS 2020
- PZZA 1993
- Fundamental
- Price
- TARS $69.09
- PZZA $44.78
- Analyst Decision
- TARS Strong Buy
- PZZA Buy
- Analyst Count
- TARS 7
- PZZA 10
- Target Price
- TARS $67.14
- PZZA $50.00
- AVG Volume (30 Days)
- TARS 737.2K
- PZZA 913.5K
- Earning Date
- TARS 11-12-2025
- PZZA 11-06-2025
- Dividend Yield
- TARS N/A
- PZZA 4.13%
- EPS Growth
- TARS N/A
- PZZA 8.47
- EPS
- TARS N/A
- PZZA 2.28
- Revenue
- TARS $295,521,000.00
- PZZA $2,085,052,000.00
- Revenue This Year
- TARS $137.28
- PZZA $4.55
- Revenue Next Year
- TARS $42.84
- PZZA $0.93
- P/E Ratio
- TARS N/A
- PZZA $19.55
- Revenue Growth
- TARS 254.45
- PZZA N/A
- 52 Week Low
- TARS $32.91
- PZZA $30.16
- 52 Week High
- TARS $69.49
- PZZA $60.75
- Technical
- Relative Strength Index (RSI)
- TARS 77.06
- PZZA 41.30
- Support Level
- TARS $56.25
- PZZA $44.84
- Resistance Level
- TARS $59.78
- PZZA $49.01
- Average True Range (ATR)
- TARS 2.58
- PZZA 1.51
- MACD
- TARS 1.15
- PZZA -0.22
- Stochastic Oscillator
- TARS 97.60
- PZZA 4.56
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.